Susan van Erp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Susan van Erp has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Ronald Jeroen Pasterkamp
Department of Translational Neuroscience, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands
7 shared publications - Casper C. Hoogenraad
Department of Neuroscience, Genentech, Inc., South San Francisco, CA 94080, USA
3 shared publications Anna Akhmanova
2 shared publicationsChris I. De Zeeuw
2 shared publicationsDick Jaarsma
2 shared publicationsEsther de Graaff
2 shared publications
Latest Publications
- Open Access
- 17 June 2020
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 12 (8) , e11674
PI 3‐kinase delta enhances axonal PIP3 to support axon regeneration in the adult CNS
Peripheral nervous system (PNS) neurons support axon regeneration into adulthood, whereas central nervous system (CNS) neurons lose regenerative ability after development. To better understand this decline whilst aiming to improve regeneration, we focused on phosphoinositide 3‐kinase (PI3K) and its product phosphatidylinositol (3,4,5)‐trisphosphate (PIP 3 ). We demonstrate that adult PNS neurons utilise two catalytic subunits of PI3K for axon regeneration: p110α and p110δ. However, in the CNS, axonal PIP 3 decreases with development at the time when axon transport declines and regenerative competence is lost. Overexpressing p110α in CNS neurons had no effect; however, expression of p110δ restored axonal PIP 3 and increased regenerative axon transport. p110δ expression enhanced CNS regeneration in both rat and human neurons and in transgenic mice, functioning in the same way as the hyperactivating H1047R mutation of p110α. Furthermore, viral delivery of p110δ promoted robust regeneration after optic nerve injury. These findings establish a deficit of axonal PIP 3 as a key reason for intrinsic regeneration failure and demonstrate that native p110δ facilitates axon regeneration by functioning in a hyperactive fashion.
- 17 June 2020
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 12 (8) , e11674
Open AccessPI 3‐kinase delta enhances axonal PIP3 to support axon regeneration in the adult CNS
Peripheral nervous system (PNS) neurons support axon regeneration into adulthood, whereas central nervous system (CNS) neurons lose regenerative ability after development. To better understand this decline whilst aiming to improve regeneration, we focused on phosphoinositide 3‐kinase (PI3K) and its product phosphatidylinositol (3,4,5)‐trisphosphate (PIP 3 ). We demonstrate that adult PNS neurons utilise two catalytic subunits of PI3K for axon regeneration: p110α and p110δ. However, in the CNS, axonal PIP 3 decreases with development at the time when axon transport declines and regenerative competence is lost. Overexpressing p110α in CNS neurons had no effect; however, expression of p110δ restored axonal PIP 3 and increased regenerative axon transport. p110δ expression enhanced CNS regeneration in both rat and human neurons and in transgenic mice, functioning in the same way as the hyperactivating H1047R mutation of p110α. Furthermore, viral delivery of p110δ promoted robust regeneration after optic nerve injury. These findings establish a deficit of axonal PIP 3 as a key reason for intrinsic regeneration failure and demonstrate that native p110δ facilitates axon regeneration by functioning in a hyperactive fashion.
- Open Access
- 8 August 2017
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 6
Selective rab11 transport and the intrinsic regenerative ability of CNS axons
Neurons lose intrinsic axon regenerative ability with maturation, but the mechanism remains unclear. Using an in-vitro laser axotomy model, we show a progressive decline in the ability of cut CNS axons to form a new growth cone and then elongate. Failure of regeneration was associated with increased retraction after axotomy. Transportation into axons becomes selective with maturation; we hypothesized that selective exclusion of molecules needed for growth may contribute to regeneration decline. With neuronal maturity rab11 vesicles (which carry many molecules involved in axon growth) became selectively targeted to the somatodendritic compartment and excluded from axons by predominant retrograde transport However, on overexpression rab11 was mistrafficked into proximal axons, and these axons showed less retraction and enhanced regeneration after axotomy. These results suggest that the decline of intrinsic axon regenerative ability is associated with selective exclusion of key molecules, and that manipulation of transport can enhance regeneration.
- 8 August 2017
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 6
Open AccessSelective rab11 transport and the intrinsic regenerative ability of CNS axons
Neurons lose intrinsic axon regenerative ability with maturation, but the mechanism remains unclear. Using an in-vitro laser axotomy model, we show a progressive decline in the ability of cut CNS axons to form a new growth cone and then elongate. Failure of regeneration was associated with increased retraction after axotomy. Transportation into axons becomes selective with maturation; we hypothesized that selective exclusion of molecules needed for growth may contribute to regeneration decline. With neuronal maturity rab11 vesicles (which carry many molecules involved in axon growth) became selectively targeted to the somatodendritic compartment and excluded from axons by predominant retrograde transport However, on overexpression rab11 was mistrafficked into proximal axons, and these axons showed less retraction and enhanced regeneration after axotomy. These results suggest that the decline of intrinsic axon regenerative ability is associated with selective exclusion of key molecules, and that manipulation of transport can enhance regeneration.
- 1 December 2015
- Published by Elsevier in Developmental Cell
- Vol. 35 (5) , 537-552
Lrig2 Negatively Regulates Ectodomain Shedding of Axon Guidance Receptors by ADAM Proteases
- 1 December 2015
- Published by Elsevier in Developmental Cell
- Vol. 35 (5) , 537-552
Lrig2 Negatively Regulates Ectodomain Shedding of Axon Guidance Receptors by ADAM Proteases
- Open Access
- 7 July 2014
- Published by Springer Nature in Nature Communications
- Vol. 5 (1) , 4380
Correction: Corrigendum: A role for Bicaudal-D2 in radial cerebellar granule cell migration
- 7 July 2014
- Published by Springer Nature in Nature Communications
- Vol. 5 (1) , 4380
Open AccessCorrection: Corrigendum: A role for Bicaudal-D2 in radial cerebellar granule cell migration
- 11 March 2014
- Published by Springer Nature in Nature Communications
- Vol. 5 (1) , 3411
A role for Bicaudal-D2 in radial cerebellar granule cell migration
Bicaudal-D (BICD) belongs to an evolutionary conserved family of dynein adaptor proteins. It was first described in Drosophila as an essential factor in fly oogenesis and embryogenesis. Missense mutations in a human BICD homologue, BICD2, have been linked to a dominant mild early onset form of spinal muscular atrophy. Here we further examine the in vivo function of BICD2 in Bicd2 knockout mice. BICD2-deficient mice develop disrupted laminar organization of cerebral cortex and the cerebellum, pointing to impaired radial neuronal migration. Using astrocyte and granule cell specific inactivation of BICD2, we show that the cerebellar migration defect is entirely dependent upon BICD2 expression in Bergmann glia cells. Proteomics analysis reveals that Bicd2 mutant mice have an altered composition of extracellular matrix proteins produced by glia cells. These findings demonstrate an essential non-cell-autonomous role of BICD2 in neuronal cell migration, which might be connected to cargo trafficking pathways in glia cells.
- 11 March 2014
- Published by Springer Nature in Nature Communications
- Vol. 5 (1) , 3411
A role for Bicaudal-D2 in radial cerebellar granule cell migration
Bicaudal-D (BICD) belongs to an evolutionary conserved family of dynein adaptor proteins. It was first described in Drosophila as an essential factor in fly oogenesis and embryogenesis. Missense mutations in a human BICD homologue, BICD2, have been linked to a dominant mild early onset form of spinal muscular atrophy. Here we further examine the in vivo function of BICD2 in Bicd2 knockout mice. BICD2-deficient mice develop disrupted laminar organization of cerebral cortex and the cerebellum, pointing to impaired radial neuronal migration. Using astrocyte and granule cell specific inactivation of BICD2, we show that the cerebellar migration defect is entirely dependent upon BICD2 expression in Bergmann glia cells. Proteomics analysis reveals that Bicd2 mutant mice have an altered composition of extracellular matrix proteins produced by glia cells. These findings demonstrate an essential non-cell-autonomous role of BICD2 in neuronal cell migration, which might be connected to cargo trafficking pathways in glia cells.
- 2 January 2014
- Published by Springer Nature in Gene Therapy
- Vol. 21 (2) , 205-211
shRNA-induced saturation of the microRNA pathway in the rat brain
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.
- 2 January 2014
- Published by Springer Nature in Gene Therapy
- Vol. 21 (2) , 205-211
shRNA-induced saturation of the microRNA pathway in the rat brain
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.
- 5 July 2013
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 341 (6141) , 77-80
Structure of the Repulsive Guidance Molecule (RGM)–Neogenin Signaling Hub
RGM Proteins: Members of the repulsive guidance molecule (RGM) family of proteins can be secreted or reside on the surface of cells where they bind to the cell surface receptor, neogenin. The RGM proteins are named for their role in axon guidance for developing neurons, but their function is also linked to a range of human diseases, including inflammation, multiple sclerosis, and cancer. Bell et al. (p. 77 ) solved the crystal structures of the external portions of the RGMB protein with portions of neogenin. The structures revealed interactions of dimers of RGMB with neogenin in which ligand binding induced conformational changes that may initiate intracellular signaling from the receptor. RGM proteins contain a site of autocatalytic cleavage that affects secretion of the proteins, and some disease-associated mutations in RGM proteins were clustered at this site.
- 5 July 2013
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 341 (6141) , 77-80
Structure of the Repulsive Guidance Molecule (RGM)–Neogenin Signaling Hub
RGM Proteins: Members of the repulsive guidance molecule (RGM) family of proteins can be secreted or reside on the surface of cells where they bind to the cell surface receptor, neogenin. The RGM proteins are named for their role in axon guidance for developing neurons, but their function is also linked to a range of human diseases, including inflammation, multiple sclerosis, and cancer. Bell et al. (p. 77 ) solved the crystal structures of the external portions of the RGMB protein with portions of neogenin. The structures revealed interactions of dimers of RGMB with neogenin in which ligand binding induced conformational changes that may initiate intracellular signaling from the receptor. RGM proteins contain a site of autocatalytic cleavage that affects secretion of the proteins, and some disease-associated mutations in RGM proteins were clustered at this site.
- Open Access
- 26 April 2012
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 69 (18) , 3127-3145
Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response
Mesial temporal lobe epilepsy (mTLE) is a chronic neurological disorder characterized by recurrent seizures. The pathogenic mechanisms underlying mTLE may involve defects in the post-transcriptional regulation of gene expression. MicroRNAs (miRNAs) are non-coding RNAs that control the expression of genes at the post-transcriptional level. Here, we performed a genome-wide miRNA profiling study to examine whether miRNA-mediated mechanisms are affected in human mTLE. miRNA profiles of the hippocampus of autopsy control patients and two mTLE patient groups were compared. This revealed segregated miRNA signatures for the three different patient groups and 165 miRNAs with up- or down-regulated expression in mTLE. miRNA in situ hybridization detected cell type-specific changes in miRNA expression and an abnormal nuclear localization of select miRNAs in neurons and glial cells of mTLE patients. Of several cellular processes implicated in mTLE, the immune response was most prominently targeted by deregulated miRNAs. Enhanced expression of inflammatory mediators was paralleled by a reduction in miRNAs that were found to target the 3′-untranslated regions of these genes in reporter assays. miR-221 and miR-222 were shown to regulate endogenous ICAM1 expression and were selectively co-expressed with ICAM1 in astrocytes in mTLE patients. Our findings suggest that miRNA changes in mTLE affect the expression of immunomodulatory proteins thereby further facilitating the immune response. This mechanism may have broad implications given the central role of astrocytes and the immune system in human neurological disease. Overall, this work extends the current concepts of human mTLE pathogenesis to the level of miRNA-mediated gene regulation.
- 26 April 2012
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 69 (18) , 3127-3145
Open AccessGenome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response
Mesial temporal lobe epilepsy (mTLE) is a chronic neurological disorder characterized by recurrent seizures. The pathogenic mechanisms underlying mTLE may involve defects in the post-transcriptional regulation of gene expression. MicroRNAs (miRNAs) are non-coding RNAs that control the expression of genes at the post-transcriptional level. Here, we performed a genome-wide miRNA profiling study to examine whether miRNA-mediated mechanisms are affected in human mTLE. miRNA profiles of the hippocampus of autopsy control patients and two mTLE patient groups were compared. This revealed segregated miRNA signatures for the three different patient groups and 165 miRNAs with up- or down-regulated expression in mTLE. miRNA in situ hybridization detected cell type-specific changes in miRNA expression and an abnormal nuclear localization of select miRNAs in neurons and glial cells of mTLE patients. Of several cellular processes implicated in mTLE, the immune response was most prominently targeted by deregulated miRNAs. Enhanced expression of inflammatory mediators was paralleled by a reduction in miRNAs that were found to target the 3′-untranslated regions of these genes in reporter assays. miR-221 and miR-222 were shown to regulate endogenous ICAM1 expression and were selectively co-expressed with ICAM1 in astrocytes in mTLE patients. Our findings suggest that miRNA changes in mTLE affect the expression of immunomodulatory proteins thereby further facilitating the immune response. This mechanism may have broad implications given the central role of astrocytes and the immune system in human neurological disease. Overall, this work extends the current concepts of human mTLE pathogenesis to the level of miRNA-mediated gene regulation.
- 15 December 2011
- Published by Wiley
Semaphorins
The semaphorins are an evolutionary conserved family of intercellular signalling proteins known to deliver guidance cues to growing axons and migrating cells during development. Semaphorins bind with high affinity to several distinct receptor families on the cell surface, including the neuropilins and plexins. The interaction of semaphorins and their receptor complexes triggers elaborate intracellular signalling pathways that in many cases regulate the cytoskeleton to control growth cone or cellular morphology. However, semaphorins also regulate cellular processes not directly related to changes in cytoskeletal dynamics such as apoptosis or cytokine release. Defects in semaphorin function have been associated with a variety of human diseases including amyotrophic lateral sclerosis, spinal cord injury and cancer, and studies have been initiated to use semaphorin proteins as therapeutic targets in human disorders. Key Concepts: Semaphorins are bi‐functional guidance cues mediating attractive and repulsive chemotactic responses. Semaphorin receptor complexes are composed of ligand binding, signal‐transducing and modulatory subunits. Context‐dependent changes in receptor or signalling components determine the downstream effect of semaphorins. Semaphorins can act as ligands and receptors, a process called bi‐directional signalling. Secreted and membrane‐associated semaphorins regulate various aspects of neural circuit development. Signalling cues that function downstream of semaphorin receptors includes protein kinases and small GTPases. Semaphorins have been implicated in various human diseases and may serve as therapeutic targets.
- 15 December 2011
- Published by Wiley
Semaphorins
The semaphorins are an evolutionary conserved family of intercellular signalling proteins known to deliver guidance cues to growing axons and migrating cells during development. Semaphorins bind with high affinity to several distinct receptor families on the cell surface, including the neuropilins and plexins. The interaction of semaphorins and their receptor complexes triggers elaborate intracellular signalling pathways that in many cases regulate the cytoskeleton to control growth cone or cellular morphology. However, semaphorins also regulate cellular processes not directly related to changes in cytoskeletal dynamics such as apoptosis or cytokine release. Defects in semaphorin function have been associated with a variety of human diseases including amyotrophic lateral sclerosis, spinal cord injury and cancer, and studies have been initiated to use semaphorin proteins as therapeutic targets in human disorders. Key Concepts: Semaphorins are bi‐functional guidance cues mediating attractive and repulsive chemotactic responses. Semaphorin receptor complexes are composed of ligand binding, signal‐transducing and modulatory subunits. Context‐dependent changes in receptor or signalling components determine the downstream effect of semaphorins. Semaphorins can act as ligands and receptors, a process called bi‐directional signalling. Secreted and membrane‐associated semaphorins regulate various aspects of neural circuit development. Signalling cues that function downstream of semaphorin receptors includes protein kinases and small GTPases. Semaphorins have been implicated in various human diseases and may serve as therapeutic targets.
- 1 September 2010
- Published by Elsevier in Trends in Cell Biology
- Vol. 20 (9) , 568-576
Semaphorin signaling: molecular switches at the midline
- 1 September 2010
- Published by Elsevier in Trends in Cell Biology
- Vol. 20 (9) , 568-576
Semaphorin signaling: molecular switches at the midline